Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

UNKNOWN 1 OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Nasopharyngeal Carcinoma 4 Lung Neoplasms 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Sarcoma 2 Respiratory Tract Diseases 2 Lung Diseases 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma, Bronchogenic 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Advanced Solid Tumor 2 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 PD-L1 Positive Non-small Cell Lung Cancer 1 Non-squamous Non-small-cell Lung Cancer 1 Non-squamous Non-small Cell Lung Cancer 1 Non Squamous Non Small Cell Lung Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Lymphoma, Extranodal NK-T-Cell 1 Hodgkin Disease 1

Interventions

Carboplatin 71 Etoposide 63 Topotecan 42 Cisplatin 38 pembrolizumab 30 atezolizumab 26 durvalumab 22 Paclitaxel 16 Nivolumab 14 PM 01183 13 rovalpituzumab tesirine 11 Pemetrexed 11 amrubicin 9 Ipilimumab 9 Injections 9 Irinotecan 8 AMG 757 8 trilaciclib 7 etoposide phosphate 6 EC regimen 6 Drug Therapy 6 Docetaxel 6 Bevacizumab 6 tremelimumab 5 MLN 8237 5 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 olaparib 4 chiauranib 4 budigalimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Small Cell Lung Carcinoma × camrelizumab × Clear all

NCT03417895 2024-08-07

PASSION

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed

59 enrolled 17 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡